Евразийская интеграция: экономика, право, политика (Dec 2022)

Pharmaceutical Market of the EAEU: Trends and Prospects of Development

  • A. A. Vorona,
  • M. A. Gubina

DOI
https://doi.org/10.22394/2073-2929-2022-04-43-54
Journal volume & issue
Vol. 0, no. 4
pp. 43 – 54

Abstract

Read online

In modern conditions, international integration in the pharmaceutical industry is becoming a necessary condition for the development of the industry. At the same time, the improvement of medical science and technology is determined by the use of innovative technologies that prevail in the market of medicines. All this determines the relevance of the study. In recent years, the pharmaceutical industry has faced serious challenges: first it was the COVID-19 pandemic, which required a significant mobilization of all scientific and production resources, operational restructuring of many processes, expansion of tools for interaction and partnership at all levels, changes in the regulatory environment, then economic restrictive measures were taken against Russia, which, although not affected drug provision, but they created considerable logistical difficulties for drug manufacturers and generated certain unrest among drug consumers.Aim. To assess the pharmaceutical market of the EAEU, identify emerging problems and outline ways to solve them.Tasks. Consider the capacity of the pharmaceutical market of the EAEU; identify problems arising in the pharmaceutical market of the EAEU; to determine the prospects for the development of the pharmaceutical market of the EAEU.Methods. Statistical analysis of data and synthesis of the results obtained for comparison purposes.Results. A study of trends in the pharmaceutical market was conducted, as a result of which generalizing conclusions were made; problems faced by the market under the influence of uncertainty and risk factors were identified; attempts were made to identify promising directions for the development of the pharmaceutical market of the EAEU.Conclusion. The conducted research makes it possible to identify problematic issues in the development of the pharmaceutical market of the EAEU and outline ways to eliminate them.

Keywords